Djibouti vs Timor-Leste: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Djibouti
82.0%
in 2025
Timor-Leste
82.0%
in 2025
Djibouti rank
106th
Timor-Leste rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Djibouti
- Timor-Leste
How they compare
Djibouti currently reports 82.0% against 82.0% in Timor-Leste, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Timor-Leste ahead.
Djibouti ranks 106th and Timor-Leste ranks 106th of 194 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 55.5% | 0.0% | 55.5% | Djibouti |
| 2020s | 69.7% | 36.5% | 33.2% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Djibouti or Timor-Leste?
- Djibouti, at 82.0% against 82.0% in Timor-Leste as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Djibouti and Timor-Leste?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Timor-Leste?
- 18 years are reported by both, from 2008 to 2025.
- How do Djibouti and Timor-Leste rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Djibouti ranks 106th and Timor-Leste ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.